CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 381 enrolled
Drug / intervention
discontinue statinsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01415934
NCT01415934N/ACompleted
CompareCT.gov

Multisite Randomized Controlled Trial of Continuing vs. Discontinuing Statins

University of Colorado, Denver·interventional·Posted Aug 12, 2011·Updated Sep 21, 2018

In Brief

A clinical study evaluating discontinue statins for Palliative Medicine and Cardiovascular Disease. Completed, enrolled 381 participants across 15 sites.

Detailed Summary

The purpose of this study is to determine if there is a difference in survival rate at 60 days after enrollment between patients with advanced life-limiting illness for whom statins are discontinued vs. for patients with advanced life-limiting illness who are maintained on the medication. Secondary outcomes of this study will determine the effects of medication cessation on overall survival, important cardiovascular events, quality of life (QOL), symptoms, performance status, polypharmacy issues, satisfaction with care, and costs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPalliative Medicine, Cardiovascular Disease
CountriesUnited States
CollaboratorsNational Institute of Nursing Research (NINR)

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 12, 2011
Enrollment StartJun 3, 2011
Primary CompletionJul 15, 2013
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 14.9 years ago

Interventions

discontinue statinsother

patients will be randomized to either continue taking statins or discontinue.